Index Fund Advisors Inc. Has $483,000 Stock Holdings in Intuitive Surgical, Inc. $ISRG

Index Fund Advisors Inc. boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 98.7% in the second quarter, Holdings Channel.com reports. The fund owned 888 shares of the medical equipment provider’s stock after buying an additional 441 shares during the quarter. Index Fund Advisors Inc.’s holdings in Intuitive Surgical were worth $483,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. grew its holdings in Intuitive Surgical by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after acquiring an additional 453,335 shares during the period. Invesco Ltd. grew its holdings in Intuitive Surgical by 1.7% during the first quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock valued at $2,090,027,000 after purchasing an additional 71,794 shares during the period. Northern Trust Corp grew its holdings in Intuitive Surgical by 0.3% during the first quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock valued at $1,798,465,000 after purchasing an additional 11,988 shares during the period. Wellington Management Group LLP grew its holdings in Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after purchasing an additional 457,080 shares during the period. Finally, Nuveen LLC acquired a new position in Intuitive Surgical during the first quarter valued at approximately $1,715,899,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of analyst reports. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, October 4th. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a report on Wednesday, October 8th. Evercore ISI decreased their price objective on shares of Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating for the company in a report on Tuesday, October 7th. Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a report on Wednesday, July 23rd. Finally, Truist Financial boosted their price objective on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 23rd. Fourteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $589.43.

Intuitive Surgical Price Performance

ISRG opened at $429.59 on Monday. The company has a market capitalization of $154.00 billion, a price-to-earnings ratio of 59.91, a P/E/G ratio of 4.51 and a beta of 1.61. The business’s 50-day moving average price is $458.68 and its two-hundred day moving average price is $497.84. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. During the same period in the prior year, the firm earned $1.78 earnings per share. Intuitive Surgical’s revenue for the quarter was up 21.4% compared to the same quarter last year. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. This represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock valued at $21,716,492 in the last quarter. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.